Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women

NCT00530582 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.

NCT NCT00530582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women
Lead sponsor
Max-Planck-Institute of Psychiatry
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2003
Completion date
July 31, 2004
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, postmenopausal